Dr. Martens (LON:DOCS) Shares Down 9.6% – Here’s What Happened

Dr. Martens plc (LON:DOCS) fell 9.6% during mid-day trading on Thursday . The stock traded as low as GBX 72.30 and last traded at GBX 73.80. 4,733,644 shares were traded during mid-day trading, an increase of 115% from the average session volume of 2,203,986 shares. The stock had previously closed at GBX 81.60.

Wall Street Analyst Weigh In

Separately, Peel Hunt reaffirmed a “buy” rating on shares of Dr. Martens in a research report on Thursday. One investment analyst has rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat, the company presently has an average rating of “Hold” and an average price target of GBX 6,000.

Dr. Martens Stock Down 9.6%

The business has a fifty day moving average price of GBX 90.30 and a two-hundred day moving average price of GBX 80.31. The company has a debt-to-equity ratio of 127.27, a current ratio of 2.85 and a quick ratio of 1.13. The firm has a market capitalization of £713.15 million, a price-to-earnings ratio of 147.60, a price-to-earnings-growth ratio of 6.40 and a beta of 0.11.

Dr. Martens (LON:DOCS) last released its quarterly earnings data on Thursday, November 20th. The company reported GBX (0.90) earnings per share for the quarter. Dr. Martens had a return on equity of 18.91% and a net margin of 7.89%. On average, equities analysts expect that Dr. Martens plc will post 2.5809394 earnings per share for the current year.

Insiders Place Their Bets

In other Dr. Martens news, insider Giles Wilson bought 105,838 shares of Dr. Martens stock in a transaction dated Monday, September 1st. The stock was acquired at an average cost of GBX 91 per share, with a total value of £96,312.58. Also, insider Ije Nwokori sold 298,675 shares of the stock in a transaction that occurred on Wednesday, October 15th. The shares were sold at an average price of GBX 90, for a total value of £268,807.50. In the last ninety days, insiders acquired 136,960 shares of company stock valued at $12,460,163 and sold 434,460 shares valued at $39,131,400. 2.80% of the stock is currently owned by insiders.

About Dr. Martens

Founded in 1960, Dr. Martens is an iconic British brand with a global presence. “Docs” or “DMs” were originally
produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical
movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history.